1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Diabetic Neuropathy Revenue 1.4 Market by Type 1.4.1 Global Diabetic Neuropathy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Peripheral Neuropathy 1.4.3 Autonomic Neuropathy 1.4.4 Proximal Neuropathy 1.4.5 Focal Neuropathy 1.5 Market by Application 1.5.1 Global Diabetic Neuropathy Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Retail Pharmacy 1.5.5 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Diabetic Neuropathy Market Perspective (2015-2026) 2.2 Global Diabetic Neuropathy Growth Trends by Regions 2.2.1 Diabetic Neuropathy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Diabetic Neuropathy Historic Market Share by Regions (2015-2020) 2.2.3 Diabetic Neuropathy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Diabetic Neuropathy Market Growth Strategy 2.3.6 Primary Interviews with Key Diabetic Neuropathy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Diabetic Neuropathy Players by Market Size 3.1.1 Global Top Diabetic Neuropathy Players by Revenue (2015-2020) 3.1.2 Global Diabetic Neuropathy Revenue Market Share by Players (2015-2020) 3.1.3 Global Diabetic Neuropathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Diabetic Neuropathy Market Concentration Ratio 3.2.1 Global Diabetic Neuropathy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Diabetic Neuropathy Revenue in 2019 3.3 Diabetic Neuropathy Key Players Head office and Area Served 3.4 Key Players Diabetic Neuropathy Product Solution and Service 3.5 Date of Enter into Diabetic Neuropathy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Diabetic Neuropathy Historic Market Size by Type (2015-2020) 4.2 Global Diabetic Neuropathy Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Diabetic Neuropathy Market Size by Application (2015-2020) 5.2 Global Diabetic Neuropathy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Diabetic Neuropathy Market Size (2015-2020) 6.2 Diabetic Neuropathy Key Players in North America (2019-2020) 6.3 North America Diabetic Neuropathy Market Size by Type (2015-2020) 6.4 North America Diabetic Neuropathy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Diabetic Neuropathy Market Size (2015-2020) 7.2 Diabetic Neuropathy Key Players in Europe (2019-2020) 7.3 Europe Diabetic Neuropathy Market Size by Type (2015-2020) 7.4 Europe Diabetic Neuropathy Market Size by Application (2015-2020) 8 China 8.1 China Diabetic Neuropathy Market Size (2015-2020) 8.2 Diabetic Neuropathy Key Players in China (2019-2020) 8.3 China Diabetic Neuropathy Market Size by Type (2015-2020) 8.4 China Diabetic Neuropathy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Diabetic Neuropathy Market Size (2015-2020) 9.2 Diabetic Neuropathy Key Players in Japan (2019-2020) 9.3 Japan Diabetic Neuropathy Market Size by Type (2015-2020) 9.4 Japan Diabetic Neuropathy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Diabetic Neuropathy Market Size (2015-2020) 10.2 Diabetic Neuropathy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Diabetic Neuropathy Market Size by Type (2015-2020) 10.4 Southeast Asia Diabetic Neuropathy Market Size by Application (2015-2020) 11 India 11.1 India Diabetic Neuropathy Market Size (2015-2020) 11.2 Diabetic Neuropathy Key Players in India (2019-2020) 11.3 India Diabetic Neuropathy Market Size by Type (2015-2020) 11.4 India Diabetic Neuropathy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Diabetic Neuropathy Market Size (2015-2020) 12.2 Diabetic Neuropathy Key Players in Central & South America (2019-2020) 12.3 Central & South America Diabetic Neuropathy Market Size by Type (2015-2020) 12.4 Central & South America Diabetic Neuropathy Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview 13.1.3 Pfizer Diabetic Neuropathy Introduction 13.1.4 Pfizer Revenue in Diabetic Neuropathy Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Janssen Pharmaceuticals 13.2.1 Janssen Pharmaceuticals Company Details 13.2.2 Janssen Pharmaceuticals Business Overview 13.2.3 Janssen Pharmaceuticals Diabetic Neuropathy Introduction 13.2.4 Janssen Pharmaceuticals Revenue in Diabetic Neuropathy Business (2015-2020) 13.2.5 Janssen Pharmaceuticals Recent Development 13.3 Eli Lilly and Company 13.3.1 Eli Lilly and Company Company Details 13.3.2 Eli Lilly and Company Business Overview 13.3.3 Eli Lilly and Company Diabetic Neuropathy Introduction 13.3.4 Eli Lilly and Company Revenue in Diabetic Neuropathy Business (2015-2020) 13.3.5 Eli Lilly and Company Recent Development 13.4 ACTAVIS 13.4.1 ACTAVIS Company Details 13.4.2 ACTAVIS Business Overview 13.4.3 ACTAVIS Diabetic Neuropathy Introduction 13.4.4 ACTAVIS Revenue in Diabetic Neuropathy Business (2015-2020) 13.4.5 ACTAVIS Recent Development 13.5 Cephalon 13.5.1 Cephalon Company Details 13.5.2 Cephalon Business Overview 13.5.3 Cephalon Diabetic Neuropathy Introduction 13.5.4 Cephalon Revenue in Diabetic Neuropathy Business (2015-2020) 13.5.5 Cephalon Recent Development 13.6 MEDA Pharma & Co. KG 13.6.1 MEDA Pharma & Co. KG Company Details 13.6.2 MEDA Pharma & Co. KG Business Overview 13.6.3 MEDA Pharma & Co. KG Diabetic Neuropathy Introduction 13.6.4 MEDA Pharma & Co. KG Revenue in Diabetic Neuropathy Business (2015-2020) 13.6.5 MEDA Pharma & Co. KG Recent Development 13.7 GlaxoSmithKline 13.7.1 GlaxoSmithKline Company Details 13.7.2 GlaxoSmithKline Business Overview 13.7.3 GlaxoSmithKline Diabetic Neuropathy Introduction 13.7.4 GlaxoSmithKline Revenue in Diabetic Neuropathy Business (2015-2020) 13.7.5 GlaxoSmithKline Recent Development 13.8 NeuroMetrix 13.8.1 NeuroMetrix Company Details 13.8.2 NeuroMetrix Business Overview 13.8.3 NeuroMetrix Diabetic Neuropathy Introduction 13.8.4 NeuroMetrix Revenue in Diabetic Neuropathy Business (2015-2020) 13.8.5 NeuroMetrix Recent Development 13.9 Johnson and Johnson 13.9.1 Johnson and Johnson Company Details 13.9.2 Johnson and Johnson Business Overview 13.9.3 Johnson and Johnson Diabetic Neuropathy Introduction 13.9.4 Johnson and Johnson Revenue in Diabetic Neuropathy Business (2015-2020) 13.9.5 Johnson and Johnson Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Diabetic Neuropathy Key Market Segments Table 2. Key Players Covered: Ranking by Diabetic Neuropathy Revenue Table 3. Ranking of Global Top Diabetic Neuropathy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Diabetic Neuropathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Peripheral Neuropathy Table 6. Key Players of Autonomic Neuropathy Table 7. Key Players of Proximal Neuropathy Table 8. Key Players of Focal Neuropathy Table 9. Global Diabetic Neuropathy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Diabetic Neuropathy Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Diabetic Neuropathy Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Diabetic Neuropathy Market Share by Regions (2015-2020) Table 13. Global Diabetic Neuropathy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Diabetic Neuropathy Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Diabetic Neuropathy Market Growth Strategy Table 19. Main Points Interviewed from Key Diabetic Neuropathy Players Table 20. Global Diabetic Neuropathy Revenue by Players (2015-2020) (Million US$) Table 21. Global Diabetic Neuropathy Market Share by Players (2015-2020) Table 22. Global Top Diabetic Neuropathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neuropathy as of 2019) Table 23. Global Diabetic Neuropathy by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Diabetic Neuropathy Product Solution and Service Table 26. Date of Enter into Diabetic Neuropathy Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 29. Global Diabetic Neuropathy Market Size Share by Type (2015-2020) Table 30. Global Diabetic Neuropathy Revenue Market Share by Type (2021-2026) Table 31. Global Diabetic Neuropathy Market Size Share by Application (2015-2020) Table 32. Global Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 33. Global Diabetic Neuropathy Market Size Share by Application (2021-2026) Table 34. North America Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 35. North America Key Players Diabetic Neuropathy Market Share (2019-2020) Table 36. North America Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 37. North America Diabetic Neuropathy Market Share by Type (2015-2020) Table 38. North America Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 39. North America Diabetic Neuropathy Market Share by Application (2015-2020) Table 40. Europe Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Diabetic Neuropathy Market Share (2019-2020) Table 42. Europe Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 43. Europe Diabetic Neuropathy Market Share by Type (2015-2020) Table 44. Europe Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 45. Europe Diabetic Neuropathy Market Share by Application (2015-2020) Table 46. China Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 47. China Key Players Diabetic Neuropathy Market Share (2019-2020) Table 48. China Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 49. China Diabetic Neuropathy Market Share by Type (2015-2020) Table 50. China Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 51. China Diabetic Neuropathy Market Share by Application (2015-2020) Table 52. Japan Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Diabetic Neuropathy Market Share (2019-2020) Table 54. Japan Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 55. Japan Diabetic Neuropathy Market Share by Type (2015-2020) Table 56. Japan Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 57. Japan Diabetic Neuropathy Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Diabetic Neuropathy Market Share (2019-2020) Table 60. Southeast Asia Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Diabetic Neuropathy Market Share by Type (2015-2020) Table 62. Southeast Asia Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Diabetic Neuropathy Market Share by Application (2015-2020) Table 64. India Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 65. India Key Players Diabetic Neuropathy Market Share (2019-2020) Table 66. India Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 67. India Diabetic Neuropathy Market Share by Type (2015-2020) Table 68. India Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 69. India Diabetic Neuropathy Market Share by Application (2015-2020) Table 70. Central & South America Key Players Diabetic Neuropathy Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Diabetic Neuropathy Market Share (2019-2020) Table 72. Central & South America Diabetic Neuropathy Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Diabetic Neuropathy Market Share by Type (2015-2020) Table 74. Central & South America Diabetic Neuropathy Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Diabetic Neuropathy Market Share by Application (2015-2020) Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Product Table 79. Pfizer Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 80. Pfizer Recent Development Table 81. Janssen Pharmaceuticals Company Details Table 82. Janssen Pharmaceuticals Business Overview Table 83. Janssen Pharmaceuticals Product Table 84. Janssen Pharmaceuticals Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 85. Janssen Pharmaceuticals Recent Development Table 86. Eli Lilly and Company Company Details Table 87. Eli Lilly and Company Business Overview Table 88. Eli Lilly and Company Product Table 89. Eli Lilly and Company Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 90. Eli Lilly and Company Recent Development Table 91. ACTAVIS Company Details Table 92. ACTAVIS Business Overview Table 93. ACTAVIS Product Table 94. ACTAVIS Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 95. ACTAVIS Recent Development Table 96. Cephalon Company Details Table 97. Cephalon Business Overview Table 98. Cephalon Product Table 99. Cephalon Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 100. Cephalon Recent Development Table 101. MEDA Pharma & Co. KG Company Details Table 102. MEDA Pharma & Co. KG Business Overview Table 103. MEDA Pharma & Co. KG Product Table 104. MEDA Pharma & Co. KG Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 105. MEDA Pharma & Co. KG Recent Development Table 106. GlaxoSmithKline Company Details Table 107. GlaxoSmithKline Business Overview Table 108. GlaxoSmithKline Product Table 109. GlaxoSmithKline Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 110. GlaxoSmithKline Recent Development Table 111. NeuroMetrix Business Overview Table 112. NeuroMetrix Product Table 113. NeuroMetrix Company Details Table 114. NeuroMetrix Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 115. NeuroMetrix Recent Development Table 116. Johnson and Johnson Company Details Table 117. Johnson and Johnson Business Overview Table 118. Johnson and Johnson Product Table 119. Johnson and Johnson Revenue in Diabetic Neuropathy Business (2015-2020) (Million US$) Table 120. Johnson and Johnson Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Diabetic Neuropathy Market Share by Type: 2020 VS 2026 Figure 2. Peripheral Neuropathy Features Figure 3. Autonomic Neuropathy Features Figure 4. Proximal Neuropathy Features Figure 5. Focal Neuropathy Features Figure 6. Global Diabetic Neuropathy Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Retail Pharmacy Case Studies Figure 10. Online Pharmacy Case Studies Figure 11. Diabetic Neuropathy Report Years Considered Figure 12. Global Diabetic Neuropathy Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Diabetic Neuropathy Market Share by Regions: 2020 VS 2026 Figure 14. Global Diabetic Neuropathy Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Diabetic Neuropathy Market Share by Players in 2019 Figure 17. Global Top Diabetic Neuropathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neuropathy as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Diabetic Neuropathy Revenue in 2019 Figure 19. North America Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Diabetic Neuropathy Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Bottom-up and Top-down Approaches for This Report Figure 27. Data Triangulation Figure 28. Key Executives Interviewed

Pfizer Janssen Pharmaceuticals Eli Lilly and Company ACTAVIS Cephalon MEDA Pharma & Co. KG GlaxoSmithKline NeuroMetrix Johnson and Johnson